ARDELYX, INC. CHANGE IN CONTROL SEVERANCE AGREEMENTChange in Control Severance Agreement • August 6th, 2020 • Ardelyx, Inc. • Pharmaceutical preparations • California
This Change in Control Severance Agreement (the “Agreement”) is made and entered into by and between Susan Rodriguez (the “Executive”) and Ardelyx, Inc. (the “Company”), effective as May 18, 2020 (the “Effective Date”).
ARDELYX, INC. CHANGE IN CONTROL SEVERANCE AGREEMENTControl Severance Agreement • August 6th, 2020 • Ardelyx, Inc. • Pharmaceutical preparations • California
This Change in Control Severance Agreement (the “Agreement”) is made and entered into by and between Justin Renz (the “Executive”) and Ardelyx, Inc. (the “Company”), effective as June 8, 2020 (the “Effective Date”).
Certain information in this document has been excluded pursuant to Regulation S-K, Item 601(b)(10). Such excluded information is not material and would likely cause competitive harm to the registrant if publicly disclosed. Manufacturing Services...Ardelyx, Inc. • August 6th, 2020 • Pharmaceutical preparations • New York
1. Interpretation 4 1.1 Definitions. 4 1.2 Interpretation. 8 2. Patheon's Manufacturing Services 8 2.1 Manufacturing Services. 8 2.2 Minimum [***] Requirement. 8 2.3 Exclusivity. 9 2.4 No Volume Guarantee. 9 2.5 No Sole Source. 9 2.6 Subcontracting. 9 2.7 Facilities. 10 3. Client's Obligations 10 3.1 Payment. 10 3.2 Processing Instructions. 10 3.3 Change Control Requests. 10 3.4 API and Components. 11 3.5 Packaging and Artwork. 12 4. Price and Price Adjustments 13 4.1 First Year Pricing. 13 4.2 Annual Price Adjustments. 13 4.3 Price Adjustments at any Time. 13 4.4 Efforts to Achieve Price Reductions. 13 5. Purchasing Product 14 5.1 Orders and Forecasts. 14 5.2 Obsolete Stock. 15 5.3 Storage. 16 5.4 Invoices and Payment. 16 5.5 Delivery and Shipping. 16 6. Product Claims and Recalls 17 6.1 Product Claims. 17 6.2 Product Recalls and Returns. 18 6.3 Disposition of Deficient Product. 19 7. Co-operation and Regulatory Affairs 19
